Take a look at some of our recent publications:
Peer reviewed publications
Efficacy and safety concerns over the use of mucus modulating agents for drug delivery using nanoscale systems.
Chater PI, Wilcox MD, Pearson JP.
Advanced drug delivery reviews (2017)
Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown.
Crouch LI, Liberato MV, Urbanowicz PA, Baslé A, Lamb CA, Stewart CJ, Cooke K, Doona M, Needham S, Brady RR, Berrington JE, Madunic K, Wuhrer M, Chater P, Pearson J, Bolam D.
Nature communications (2020)
ζ potential changing nanoparticles as cystic fibrosis transmembrane conductance regulator gene delivery system: an in vitro evaluation.
Prüfert F, Bonengel S, Köllner S, Griesser J, Wilcox MD, Chater PI, Pearson JP, and Bernkop-Schnürch A.
The properties of the mucus barrier, a unique gel–how can nanoparticles cross it?
Pearson JP, Chater PI, Wilcox MD.
Therapeutic delivery (2016)
The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine.
Wilcox MD, Van Rooij LK, Chater PI, Pereira de Sousa I, Pearson JP
European Journal of Pharmaceutics and Biopharmaceutics (2015)
Want to talk to us?
We’re a team of scientists who are excited about unique ideas and want to help our customers do great things.